RE:Forward-Thinking Investing Well said, I always appreciate your posts. My strategies have been the same as yours NedStark. Bought into canopy at 1.80 and ACB at 54 cents. Since then have held nearly every stock at some point. Made good gains on the lay APH run and moved it all to TNY. This is my largest holding now at 270000 shares. The only other stock I hold is a pharma potential stock in TBP.
I too will buy back into APH and most likely ACB or WEED early next year.
i have spend hours everyday for the last couple years reading about MJ stocks. Now I mostly follow Tinley and fell I have researched mostly all I can to understand the full potential that his company could reach.
Good Luck All!
NedStark wrote: The attention that Tinley received this weekend, by attendants at the Cannabis Cup and investors on social media and Stockhouse, may finally be the tipping point for this company.
Leading up to this past week/weekend, it seemed as though that many investors either 1) didn’t know about Tinley, 2) knew about them but didn’t do a deep analysis of their operations, or 3) knew about them, did their research, and thought that it wouldn’t be a good investment. The first two reasons are fair, but the last reason would be mind boggling to me, which is obvious based on the history of my posts. If there are investors that still don’t see the explosive potential in Tinley, then they are either blind or are very shortsighted and not able to envision what the future will hold.
I have been researching the marijuana industry for about 2 years now, but did not get serious about it until early last summer. My first MJ investments were in Canopy, Aphria, and Mettrum, and I will admit that I got in late (compared to when I personally should have bought in) because the initial big boom happened a lot sooner than I had anticipated and I was hesitant on when to pull the trigger. I ended up buying into Canopy at $3.82, Aphria at $2.59, and Mettrum at $3.02: Earlier than some but later than many.
I have since sold Canopy (and, therefore, Mettrum) and Aphria because I believe that recreational sales have already been priced into them. HOWEVER, I do plan on buying back into both of those companies at some point and holding them for the long-term. I honestly believe that Canopy will become the AB-InBev of Marijuana and that Aphria will end up being the number 1 leader on the pharmaceutical side of things. I may also buy Emblem or Aurora, but do not plan on owning anymore than 3 of the LP’s.
My focus right now is on companies that are going after the derivative market (oils, edibles, etc.) and pharmaceutical market. My goal as an investor in the MJ industry (and in general) is to be two steps ahead of everyone else. I believe that is how the real money is made. Edibles and other forms of marijuana are going to be the biggest market because the margins are higher and a larger portion of the mass population will be drawn to this method of consumption. As for pharma and the development of drugs, I think that this is where the biggest return on investment will be. Based on my research, personal stories of people that I know, and other key indicators (Vic Neufield, John Stewart, and the success of GW Pharma), I strongly believe that marijuana is going to cure many, many diseases. And this obviously equals big dollars for those companies. Don’t get me wrong, the recreational market is going to be huge and make people a lot of money…but I still think that long-term, the pharmaceutical market will have a bigger impact on society and provide better returns for investors.
Anyway, back to Tinley. I have nothing more to preach about them at the moment, but I will say that they are my biggest holding right now. The reason is plain and simple: I view them as providing me with the biggest returns this year out of any other company in the industry (the pharma companies that I am in are longer term investments and the only other company that might compete with Tinley is Golden Leaf Holdings – if you haven’t looked into them yet then I highly recommend you do so – their CEO is more experienced than both Vic Neufield and John Stewart, which is hard to believe). My plan is for Tinley and Golden Leaf Holdings to be my two biggest holdings long-term, and then Canopy and Aphria, and then the pharma companies.
In closing, I want to make it clear that my investment strategy is for long-term investing. I am not a trader and will never be a trader. And I don’t claim to be some sort of investment guru. I’m just an investor who has become obsessed with the marijuana industry and has done a ridiculous amount of research. This is the approach that I am taking for this new, burgeoning industry, which in my opinion could be one of the best investment opportunities that we will see in our lifetime. I obviously believe that it is the right approach to take, but this post was not meant to provide you with investment advice. It was simply meant to give you a new perspective if, up until this point, you haven't yet invested in Tinley and have strictly focused on investing in the Canadian licensed producers.